Epigenomics AG (EPGNF)
USD 0.79
(0.0%)
USD 0.79
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -5.71 Million | -12.02 Million | -4.15 Million | -9.57 Million | -13.5 Million | -10.35 Million |
| Net Income | -4.46 Million | -12.02 Million | -2.42 Million | -11.68 Million | -17.02 Million | -12.69 Million |
| Depreciation & Amortization | 563 Thousand | 749 Thousand | 419 Thousand | 535 Thousand | 513 Thousand | 308 Thousand |
| Deferred income taxes | - | -59 Thousand | -1.31 Million | - | 2.44 Million | -765 Thousand |
| Stock-based compensation | - | -35 Thousand | 98 Thousand | 631 Thousand | 873 Thousand | 1.15 Million |
| Change in working capital | -345 Thousand | -705 Thousand | -988 Thousand | 914 Thousand | -211 Thousand | 1.11 Million |
| Other non-cash items | -1.46 Million | 50 Thousand | 57 Thousand | 35 Thousand | -107 Thousand | 534 Thousand |
| Investing Cash Flow | 68 Thousand | -1.7 Million | 961 Thousand | 3000.00 | 47 Thousand | 724 Thousand |
| Investments in PPE | -3000.00 | -1.36 Million | -35 Thousand | -21 Thousand | -122 Thousand | -106 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | 984 Thousand | - | - | - |
| Other Investing Activities | 71 Thousand | -335 Thousand | 12 Thousand | 24 Thousand | 122 Thousand | 830 Thousand |
| Financing Cash Flow | -57 Thousand | -359 Thousand | 21.61 Million | 2.98 Million | 7.12 Million | 13.27 Million |
| Debt repayment | -12 Thousand | -18 Thousand | -19.8 Million | -268 Thousand | -229 Thousand | -6.02 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -45 Thousand | - | -79 Thousand | -748 Thousand | -983 Thousand | -1.95 Million |
| Common Stock Issuance | - | - | 2.16 Million | 3.99 Million | 8.33 Million | 21.25 Million |
| Other Financing Activities | - | -341 Thousand | 59.05 Million | 268 Thousand | 229 Thousand | 13.27 Million |
| Accounts receivables | - | -11 Thousand | 176 Thousand | -159 Thousand | 84 Thousand | 782 Thousand |
| Accounts payables | - | -404 Thousand | -1.19 Million | 420 Thousand | 118 Thousand | -776 Thousand |
| Inventory | -196 Thousand | 118 Thousand | -52 Thousand | 185 Thousand | 45 Thousand | -66 Thousand |
| Other working capital | -149 Thousand | -408 Thousand | 82 Thousand | 468 Thousand | -458 Thousand | 1.17 Million |
| Cash at beginning of period | 7.8 Million | 23.04 Million | 3.56 Million | 10.15 Million | 16.48 Million | 12.82 Million |
| Cash at end of period | 2.1 Million | 10.12 Million | 23.04 Million | 3.56 Million | 10.15 Million | 16.48 Million |
| Capital Expenditure | -3000.00 | -1.36 Million | -35 Thousand | -21 Thousand | -122 Thousand | -106 Thousand |
| Effect of forex changes on cash | - | 1.16 Million | 1.05 Million | -3000.00 | 7000.00 | 14 Thousand |
| Net cash flow / Change in cash | -5.7 Million | -12.92 Million | 19.48 Million | -6.58 Million | -6.33 Million | 3.66 Million |
| Free Cash Flow | -5.71 Million | -13.38 Million | -4.18 Million | -9.59 Million | -13.62 Million | -10.45 Million |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -4.46 Million | 1.88 Million | 1.88 Million | -2.63 Million | -5.59 Million | -12.02 Million |
| Depreciation & Amortization | 563 Thousand | -639 Thousand | -639 Thousand | 579 Thousand | 1.26 Million | 749 Thousand |
| Deferred income taxes | - | - | - | 2.79 Million | 58 Thousand | -59 Thousand |
| Stock-based compensation | - | - | - | 4000.00 | 10 Thousand | -35 Thousand |
| Change in working capital | -345 Thousand | -271.5 Thousand | -271.5 Thousand | -3.92 Million | 1.05 Million | -705 Thousand |
| Other non-cash items | -1.46 Million | -588.73 Thousand | -588.73 Thousand | -2000.00 | -78 Thousand | 50 Thousand |
| Investing Cash Flow | 68 Thousand | 24.5 Thousand | 24.5 Thousand | 9000.00 | 10 Thousand | -1.7 Million |
| Investments in PPE | -3000.00 | 5000.00 | 5000.00 | -1000.00 | -12 Thousand | -1.36 Million |
| Acquisitions | - | - | - | 2000.00 | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 71 Thousand | 19.5 Thousand | 19.5 Thousand | 8000.00 | 22 Thousand | -335 Thousand |
| Financing Cash Flow | -57 Thousand | 77.5 Thousand | 77.5 Thousand | -94 Thousand | -118 Thousand | -359 Thousand |
| Debt repayment | -12 Thousand | - | - | -1000.00 | -6000.00 | -18 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -45 Thousand | -12 Thousand | -12 Thousand | -2000.00 | -21 Thousand | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | 89.5 Thousand | 89.5 Thousand | -91 Thousand | -91 Thousand | -341 Thousand |
| Accounts receivables | - | 62.5 Thousand | 62.5 Thousand | -125 Thousand | -650 Thousand | -11 Thousand |
| Accounts payables | - | - | - | -3.71 Million | 650 Thousand | -404 Thousand |
| Inventory | -196 Thousand | -128 Thousand | -128 Thousand | - | 60 Thousand | 118 Thousand |
| Other working capital | -149 Thousand | -206 Thousand | -206 Thousand | -84 Thousand | 997 Thousand | -408 Thousand |
| Cash at beginning of period | 7.8 Million | - | 3.58 Million | 6.88 Million | 10.12 Million | 23.04 Million |
| Cash at end of period | 2.1 Million | 421 Thousand | 4 Million | 3.58 Million | 6.88 Million | 10.12 Million |
| Capital Expenditure | -3000.00 | 5000.00 | 5000.00 | -1000.00 | -12 Thousand | -1.36 Million |
| Effect of forex changes on cash | - | -55 Thousand | -55 Thousand | -41 Thousand | 151 Thousand | 1.16 Million |
| Net cash flow / Change in cash | -5.7 Million | 421 Thousand | 421 Thousand | -3.3 Million | -3.23 Million | -12.92 Million |
| Free Cash Flow | -5.71 Million | 379 Thousand | 379 Thousand | -3.17 Million | -3.29 Million | -13.38 Million |
SEPGF
UNRYLMA
JFL
WEBC
CSWCZ
0166